Cargando…

Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs

Chronic infection with hepatitis B virus (HBV) remains a problem of global significance and improving available treatment is important to prevent life-threatening complications arising in persistently infected individuals. HBV is susceptible to silencing by exogenous artificial intermediates of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maepa, Mohube Betty, Ely, Abdullah, Grayson, Wayne, Arbuthnot, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415967/ https://www.ncbi.nlm.nih.gov/pubmed/28624194 http://dx.doi.org/10.1016/j.omtn.2017.04.007

Ejemplares similares

Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018)

ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
por: Scott, Tristan, et al.
Publicado: (2017)

Progress and Prospects of Anti-HBV Gene Therapy Development
por: Maepa, Mohube B., et al.
Publicado: (2015)

Inhibition of Hepatitis B Virus Replication by Helper Dependent Adenoviral Vectors Expressing Artificial Anti-HBV Pri-miRs from a Liver-Specific Promoter
por: Mowa, Mohube Betty, et al.
Publicado: (2014)

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
por: Ely, Abdullah, et al.
Publicado: (2021)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021)

In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
por: Limani, Shonisani Wendy, et al.
Publicado: (2021)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020)

Hepatitis B Virus Research in South Africa
por: Maepa, Mohube B., et al.
Publicado: (2022)

Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma
por: Samudh, Nazia, et al.
Publicado: (2022)

The state of gene therapy research in Africa, its significance and implications for the future
por: Arbuthnot, P, et al.
Publicado: (2017)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
por: Bloom, Kristie, et al.
Publicado: (2013)

Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
por: Bloom, Kristie, et al.
Publicado: (2019)

Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
por: Kan, Fangming, et al.
Publicado: (2017)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018)

Establishment of stable cell lines in which the HBV genome replicates episomally for evaluation of antivirals
por: Sun, Suofeng, et al.
Publicado: (2018)

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Antiviral Gene Therapy: Summary and Perspectives
por: Arbuthnot, Patrick
Publicado: (2015)

T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
por: Sang, Xiuxiu, et al.
Publicado: (2017)

Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells
por: Green, Victoria A, et al.
Publicado: (2012)

Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles
por: Ely, Abdullah, et al.
Publicado: (2009)

Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2017)

Novel Mutant AAV2 Rep Proteins Support AAV2 Replication without Blocking HSV-1 Helpervirus Replication
por: Seyffert, Michael, et al.
Publicado: (2017)

Antiviral therapy of chronic HBV infection in pregnancy
por: Nikolajuk-Stasiuk, Julita, et al.
Publicado: (2016)

Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly
por: Xiao, Yu, et al.
Publicado: (2019)

Immunosuppressive Drugs Modulate the Replication of Hepatitis B Virus (HBV) in a Hydrodynamic Injection Mouse Model
por: Wang, Junzhong, et al.
Publicado: (2014)

Viral and Cellular Components of AAV2 Replication Compartments
por: Vogel, Rebecca, et al.
Publicado: (2013)

Vaccinia virus as a subhelper for AAV replication and packaging
por: Moore, Andrea R, et al.
Publicado: (2015)

The function of DNA binding protein nucleophosmin in AAV replication
por: Satkunanathan, Stifani, et al.
Publicado: (2017)

Author Correction: Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2018)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
por: Gu, Jin-Gang, et al.
Publicado: (2011)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Advances in HBV infection and replication systems in vitro
por: Xu, Ruirui, et al.
Publicado: (2021)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rt735ca4aufghgp6db6sss328k